53

Kimia Biosciences LtdBOM 530313 Stock Report

Last reporting period 31 Mar, 2024

Updated 04 Nov, 2024

Last price

Market cap $B

0.011

Micro

Exchange

XBOM - Bombay Stock Exchange

530313.BO Stock Analysis

53

Uncovered

Kimia Biosciences Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-21/100

Low score

Market cap $B

0.011

Dividend yield

Shares outstanding

47.31 B

Kimia Biosciences Ltd. engages in the manufacture and distribution of pharmaceutical products. The company is headquartered in New Delhi, Delhi and currently employs 241 full-time employees. The company went IPO on 2016-03-21. The firm provides its products under various categories: active pharmaceutical ingredients (APIs), intermediates and formulations. The firm's commercial products include acotiamide hydrochloride hydrate, azelnidipine, benfotiamine, benidipine hydrochloride, citicoline sodium, gliclazide, levosulpiride, luliconazole, oxaceprol, prucalopride succinate, teneligliptin hydrobromide hydrate, vildagliptin, fimasartantrihydrate potassium, obeticholic acid and ursodeoxycholic acid.

View Section: Eyestock Rating